Imcyse

Imcyse is a clinical-stage biopharmaceutical company committed to advancing the development of a new class of specific immunotherapies. Focused on severe autoimmune diseases, the Company’s unique Imotope^TM platform has the potential to make a meaningful impact on a wide range of indications in the field of autoimmunity, as well as other diseases where immune system control breaks down.